Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Social determinants of health in older adults: Current and emerging challenges.

International psychogeriatrics·2026
Same author

Do subjective cognitive complaints and slow gait speed increase the probability of progression to objective cognitive impairment? A systematic review and meta-analysis on motoric cognitive risk syndrome.

GeroScience·2026
Same author

The role of verbal episodic memory in progression to mild cognitive impairment: The influence of serial position effects.

International psychogeriatrics·2026
Same author

Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer.

The Journal of clinical investigation·2026
Same author

Identifying Facilitators and Obstacles in Piloting Dementia Initiatives Within a Living Lab Approach: Systematic Review.

JMIR aging·2026
Same author

Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

临床表现 临床表现

David Facal1,2,3, Ana I Rodríguez-Pérez3,4,5, Fátima Fernández-Feijoo1,2

  • 1Instituto de Psicoloxía (IPsiUS), Universidade de Santiago de Compostela, Santiago de Compostela, Galicia, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

认知虚弱 (CF) 与血阿尔茨海默病 (AD) 标志物有关,与没有认知衰退的身体虚弱 (PPF) 相比,在潜在可逆认知前虚弱 (PRCPF) 中发现的水平更高. 这表明认知状态在这些生物标志物方面比功能状态更有影响力.

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

相关实验视频

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学领域:

  • 老年学是指老年学的学科.
  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物

背景情况:

  • 认知虚弱 (CF) 涉及同时出现的身体虚弱和认知障碍,不包括痴呆症.
  • 肌痛性肌痛是潜在的可逆性,特别是在身体脆弱前期 (PPF) 和主观认知衰退 (SCD) 时.
  • 虽然存在神经成像与CF的联系,但像NfL,Ab42,Ab40,t-Tau,p-tau181和p-tau217这样的血阿尔茨海默病 (AD) 生物标志物在这一背景下研究较少.

研究的目的:

  • 研究血AD生物标志物与认知脆弱 (CF) 状态之间的关系.
  • 为了比较不同脆弱性和认知状态中的特定血AD生物标志物的水平.
  • 探索是否认知或功能状态与患有CF风险的个体的血AD生物标志物更强烈相关.

主要方法:

  • 分析了325名参与者的血样本,使用超敏感的单分子阵列 (SIMOA) 技术.
  • 含有NfL,Aβ-40,Aβ-42,tau,p-tau217和p-tau181.1.的量化度是什么
  • 在非脆弱,没有认知衰退的PPF,RCPF和PRCPF组之间比较生物标志物水平.

主要成果:

  • 在不同组之间观察到NfL和p-Tau217水平的显著差异.
  • 与PRCPF组相比,在没有认知衰退的PPF组中发现了较低的NfL和p-Tau217水平.
  • 这些发现表明,特定的血AD生物标志物与虚弱谱内的认知状态之间存在联系.

结论:

  • 血AD生物标志物水平似乎与参与者的认知状态更密切相关,而不是他们的功能状态.
  • 需要使用回归模型进行进一步的研究,以确认CF状态作为依赖变量,用血AD生物标志物和功能标志物作为预测因素.
  • 这项研究强调了血生物标志物在理解和潜在地管理认知脆弱方面的潜在作用.